View Older Stories View More Recent Stories
-
Atkore International Group Inc. Announces Pricing of Secondary Public Offering of Common Stock
-
The Trade Desk, Inc. (TTD) Files to Offer Stock
-
AerCap Holdings N.V. Announces Completion of Amendment, Extension and Upsizing of Unsecured Revolver
-
The Trade Desk Files Registration Statement for Proposed Follow-On Offering
-
Orchid Island Capital Announces Fourth Quarter 2016 Results
-
Aralez to Present at the RBC Capital Markets Global Healthcare Conference
-
Chemed Corporation to Present at the 2017 RBC Capital Markets’ Global Healthcare Conference
-
ABIVAX to Participate in RBC Capital Markets Global Healthcare Conference on February 22-23, 2017 in New York City
-
Financial 15 Split Corp. Announces Successful Overnight Offering
-
Valeant Pharma (VRX): Siliq Approval Earlier Than Expected - RBC
-
RBC Capital Remains Bullish on Kraft Heinz (KHC) Following 4Q Report
-
Assembly Biosciences (ASMB) Completes Dose Ranging Portion of Phase 1a/1b Trial of ABI-H0731
-
Synopsys (SNPS) PT Raised to $77 at RBC Capital Following Full Year Guidance Raise
-
Neos Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare Conference
-
Assembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference Presentations
-
Spectrum Pharmaceuticals to Present Corporate Update at the 2017 RBC Capital Markets Global Healthcare Conference on February 23rd
-
NetApp (NTAP) PT Raised to $45 at RBC Capital; Reiterates Sector Perform
-
GoDaddy (GDDY): Modestly Slowing But Stable - RBC
-
Dynavax to Present at the 2017 RBC Capital Markets Global Healthcare Conference
-
Applied Materials (AMAT) PT Raised to $35 at RBC Capital Following Strong April-Q Guidance
-
Groupon, Inc. (GRPN) PT Raised to $5 at RBC Capital
-
Martin Midstream Partners L.P. Announces Pricing of Public Offering of Common Units
-
Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference
-
Esperion to Participate in Fireside Chat at RBC Capital Markets Global Healthcare Conference
-
Immunomedics Sends Letter to Stockholders Highlighting Value Creating Global Licensing Agreement, Underscoring Fulfillment of Promise to Stockholders
-
Martin Midstream Partners (MMLP) Commences 2.6M Offering of Common Units
-
Analog Devices (ADI) PT Raised to $90 at RBC Capital; Reiterates Outperform
-
Martin Midstream Partners L.P. Announces Commencement of Public Offering of Common Units
-
Atkore International Group Inc. Announces Launch of Secondary Public Offering of Common Stock
-
Wix.com (WIX) PT Raised to $59 at RBC Capital Following 4Q Report
-
Financial 15 Split Corp. Announces Overnight Offering
-
Community Health Systems to Participate in the 2017 RBC Capital Markets Global Healthcare Conference
-
LifePoint Health to Participate in RBC Capital Markets 2017 Healthcare Conference
-
Pacira Pharmaceuticals, Inc. to Present at the 2017 RBC Capital Markets’ Healthcare Conference
-
Trian's P&G stake raises investor hopes of break-up, cost cuts
-
LHC Group to Present at RBC Capital Markets 2017 Healthcare Conference
-
Cambrex to Present at the 2017 RBC Capital Markets Global Healthcare Conference
-
ACETO to Present at the 2017 RBC Capital Markets Global Healthcare Conference
-
Flexion Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
-
Boston Scientific to Participate in 2017 RBC Capital Markets Global Healthcare Conference
-
Zogenix to Participate in the 2017 RBC Capital Markets Healthcare Conference
-
Blueprint Medicines to Present at 2017 RBC Capital Markets Global Healthcare Conference
-
RBC Capital Starts KEYW (KEYW) at Outperform
-
Incyte (INCY) PT Raised to $138 at RBC Capital Citing Growth in Jakafi
-
Aerie Pharmaceuticals to Present at the RBC Capital Markets 2017 Global Healthcare Conference
-
Campbell Soup (CPB) PT Raised to $63 at RBC Capital Ahead of 2Q17 Report
-
Insys Therapeutics, Inc. to Present at 2017 RBC Capital Markets Global Healthcare Conference
-
Puma Biotechnology to Present at RBC Capital Markets Healthcare Conference
-
Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update
-
Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update

